Will a contrarian leader be good for the Food and Drug Administration? Which ATTR-CM drug will have the best launch? And what are the hosts making for their holiday dinners?
We discuss all that and more on this week's episode of "The Readout LOUD," STAT's biotech podcast. STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.
Listen Now
Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode
Visit the archive to see past episodes
No comments